Amphastar Pharmaceuticals, Inc.
AMPHUS売上高
$720M
百万USD
営業利益
$140M
百万USD
純利益
$98M
百万USD
ROE
-
最新FY
EPS
$2.03
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $103M | $5M | $0.10 |
| FY2021 | Q2 | $102M | $8M | $0.16 |
| FY2021 | Q3 | $112M | $30M | $0.59 |
| FY2021 | FY | $438M | $62M | $1.25 |
| FY2022 | Q1 | $120M | $24M | $0.47 |
| FY2022 | Q2 | $123M | $17M | $0.33 |
| FY2022 | Q3 | $120M | $16M | $0.30 |
| FY2022 | FY | $499M | $91M | $1.74 |
| FY2023 | Q1 | $140M | $26M | $0.50 |
| FY2023 | Q2 | $146M | $26M | $0.49 |
| FY2023 | Q3 | $181M | $49M | $0.91 |
| FY2023 | FY | $644M | $138M | $2.60 |
| FY2024 | Q1 | $172M | $43M | $0.81 |
| FY2024 | Q2 | $182M | $38M | $0.73 |
| FY2024 | Q3 | $191M | $40M | $0.78 |
| FY2024 | FY | $732M | $160M | $3.06 |
| FY2025 | Q1 | $171M | $25M | $0.51 |
| FY2025 | Q2 | $174M | $31M | $0.64 |
| FY2025 | Q3 | $192M | $17M | $0.37 |
| FY2025 | FY | $720M | $98M | $2.03 |
| FY2026 | Q1 | $171M | $6M | $0.14 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $295M | $322M | $350M | $438M | $499M | $644M | $732M | $720M |
| 営業利益 | $16M | $-1M | $-9M | $-0M | $11M | $70M | $107M | $197M | $205M | $140M |
| 純利益 | $11M | $5M | $-6M | $49M | $1M | $62M | $91M | $138M | $160M | $98M |
| 総資産 | $428M | $455M | $514M | $587M | $631M | $672M | $742M | $1.5B | $1.6B | $1.6B |
| 純資産 | - | - | $364M | $428M | $449M | $446M | $529M | $639M | $732M | $789M |
| 自己資本 | $329M | $337M | $332M | $381M | $402M | $446M | - | - | - | - |
| 営業CF | - | $39M | $38M | $42M | $57M | $98M | $89M | $184M | $213M | $156M |
| EPS | $0.22 | $0.09 | $-0.12 | $0.98 | $0.03 | $1.25 | $1.74 | $2.60 | $3.06 | $2.03 |
| BPS | $7.17 | $7.28 | $7.11 | $8.25 | $8.48 | $9.25 | - | - | - | - |
| ROE | 3.2% | 1.3% | -1.7% | 12.8% | 0.3% | 13.9% | - | - | - | - |